Showing 29–56 of 96 results
Erbitux is the brand name for cetuximab, a monoclonal antibody used in the treatment of certain types of cancer. It belongs to a class of targeted therapies known as epidermal growth factor receptor (EGFR) inhibitors.
Erlonat contains erlotinib, a targeted anti-cancer medicine used primarily for the treatment of advanced or metastatic Non-Small Cell Lung Cancer and Pancreatic Cancer.
Evermil 5 Tablet is used for the prevention of organ rejection in transplant patients. It regulates the body’s immune response, so the body can accept the new organ. It is also used in combination with other medicines to treat cancers of breast, pancreas, lungs, and kidney.
Evermil 10 Tablet is used for the prevention of organ rejection in transplant patients. It regulates the body’s immune response, so the body can accept the new organ. It is also used in combination with other medicines to treat cancers of breast, pancreas, lungs, and kidney.
Femara 2.5mg Tablet helps treat breast cancer in post-menopausal women. It may be used alone or with other treatments, such as surgery or radiation. It can also be used in patients with advanced breast cancer to stop the tumor from spreading to other parts of the body.
Folotyn is primarily used to treat:
Geftinat 250mg Tablet is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.
Glivec 100mg Tablet is used to treat several types of cancers. It is most commonly prescribed to treat blood cancers (chronic myeloid leukemia and acute lymphocytic leukemia) and gastrointestinal stromal tumors. It works by targeting specific proteins that contribute to the growth and spread of cancer cells.
Glivec 400mg Tablet is used to treat several types of cancers. It is most commonly prescribed to treat blood cancers (chronic myeloid leukemia and acute lymphocytic leukemia) and gastrointestinal stromal tumors. It works by targeting specific proteins that contribute to the growth and spread of cancer cells.
Glumetinib is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition factor (MET) exon 14 skipping mutations (METex14 skipping).
Hernexeos (Zongertinib): A Targeted Therapy for HER2-Mutant Non-Small Cell Lung Cancer
Zongertinib is a next-generation, oral tyrosine kinase inhibitor (TKI) developed for the treatment of patients with HER2-mutant non-small cell lung cancer (NSCLC).
Trastuzumab targets the HER2 (Human Epidermal Growth Factor Receptor 2) protein found in excess on some cancer cells. By binding to HER2 receptors, it slows or stops cancer cell growth and helps the immune system destroy cancer cells.
Hodpro 50 mg Capsule contains procarbazine, an anticancer medicine used primarily in the treatment of Hodgkin’s lymphoma (Hodgkin’s disease). It belongs to a group of medicines known as antineoplastic or chemotherapy agents.
Hyrnuo is indicated for the treatment of adult patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) harboring activating HER2 (ERBB2) mutations, who have received at least one prior systemic therapy.
IMFINZI Injection (Durvalumab): An Advanced Immunotherapy for Cancer Treatment IMFINZI Injection contains durvalumab, a monoclonal antibody that belongs to a class of medicines known as immune checkpoint inhibitors. It is designed to help the body’s immune system recognize and attack cancer cells more effectively. Unlike traditional chemotherapy, which directly targets rapidly dividing cells, IMFINZI works…
Inlybest (Axitinib) is an important targeted therapy for advanced kidney cancer. By blocking cancer growth signals and reducing tumor blood supply, it can help slow disease progression.
Interferon Gamma-1b is a recombinant form of human interferon-gamma, a naturally occurring cytokine that plays a critical role in innate and adaptive immunity. It enhances macrophage activation, increases antigen presentation, and promotes cellular immune responses against infectious agents.
Iressa is a prescription cancer medicine used mainly in the treatment of non-small cell lung cancer (NSCLC), particularly in patients whose tumors have specific mutations in the epidermal growth factor receptor (EGFR) gene. What Iressa is used for Iressa is primarily prescribed for: Advanced or metastatic non-small cell lung cancer (NSCLC) Patients with EGFR mutation-positive…
Kisqali is a prescription medicine used in combination with endocrine therapy to treat certain types of breast cancer in adults. It is developed by Novartis and belongs to a class of medicines called CDK4/6 inhibitors.
Kryxana (ribociclib) is an important targeted therapy for HR-positive, HER2-negative advanced breast cancer. By inhibiting CDK4/6 enzymes, it helps slow cancer growth and can improve progression-free survival when used with hormone therapy.
Lenalidomide 10 mg is an immunomodulatory medicine used in the treatment of certain blood cancers and blood-related disorders. It works by affecting the immune system, inhibiting the growth of abnormal cells, and reducing the formation of blood vessels that support tumor growth.
Lenalidomide 15 mg is an immunomodulatory medication used in the treatment of certain blood cancers and hematologic disorders. It belongs to a class of drugs known as immunomodulatory agents and works by affecting the immune system, inhibiting the growth of abnormal cells, and reducing the formation of blood vessels that support tumor growth.
Lenalidomide 25 mg is an immunomodulatory medication primarily used in the treatment of certain blood cancers and bone marrow disorders. It is a derivative of thalidomide and works by affecting the immune system, inhibiting the growth of abnormal cells, and reducing the formation of new blood vessels that support tumor growth.
Lenalidomide 5 mg is an immunomodulatory medication used primarily in the treatment of certain blood cancers and hematological disorders.
Lenvat (Lenvatinib): Overview, Uses, and Safety Information Lenvat (lenvatinib) is an oral anticancer medication classified as a tyrosine kinase inhibitor (TKI). It works by blocking specific proteins involved in tumor growth and the formation of new blood vessels that supply cancer cells. By targeting these pathways, lenvatinib can help slow or stop the progression of…
Lenvat (lenvatinib) is an oral anticancer medication classified as a tyrosine kinase inhibitor (TKI). It works by blocking specific proteins involved in tumor growth and the formation of new blood vessels that supply cancer cells. By targeting these pathways, lenvatinib can help slow or stop the progression of certain cancers.
Lenvima targets multiple receptor tyrosine kinases involved in tumor angiogenesis and cancer progression. By inhibiting these pathways, it may help slow tumor growth and limit the blood supply that tumors need to grow and spread.
Lenvima targets multiple receptor tyrosine kinases involved in tumor angiogenesis and cancer progression. By inhibiting these pathways, it may help slow tumor growth and limit the blood supply that tumors need to grow and spread.